Concepedia

Publication | Open Access

Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019

DOIFull Paper Access

45

Citations

21

References

2023

Year

Swapnil Hiremath, Peter G. Blake, Angie Yeung, Michaeline McGuinty, Doneal Thomas, Jane Ip, Pierre Antoine Brown, Michael Pandes, Andrew Burke, Qazi Zain Sohail,
Clinical Journal of the American Society of Nephrology

Abstract

A modified dose of nirmatrelvir/ritonavir use was found to be safe and well tolerated, with no serious adverse events being observed in a small sample of maintenance dialysis patients.

References

YearCitations

Page 1